HD LifeSciences Surpasses 2500 Implant Milestone for HIVE™ Interbody Fusion Device

BOSTON, MA, August 11, 2020 –

HD Lifesciences, LLC, a medical device company, has announced it has surpassed the milestone of 2500 implanted HIVE™ interbody devices since the formation of the company in late 2017.

Hive™ Soft Titanium® combines the benefit of high definition 3D printed titanium with a proprietary NanoHive® surface treatment. The Soft Titanium® structural lattice design provides the ability to control implant stiffness while offering unrivaled durability. Hive™ technology with NanoHive® surfacing provides the ideal elastic modulus, diagnostic imaging, and osteogenic properties.

“HD started with the goal of creating the ideal structural lattice for orthopedic and spine applications,” says David Rattigan, Vice President of Sales. “We are very proud of reaching this milestone. Surgeons understand the progression of spinal implant materials, and we believe Hive™ implants are at the forefront of spinal fusion technology.”

HD Lifesciences, LLC interbody fusion devices are proudly made in the USA.

About HD LifeSciences, LLC

HD Lifesciences is transforming orthopedic and spinal care with our Hive™ Soft Titanium® technology. The Hive™ lattice with NanoHive® Surfacing provides ideal elastic modulus, diagnostic imaging, and osteogenic properties. Founded with a mission to improve surgical methods and devices, HD LifeSciences brings together science and engineering to improve patient care.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button